Intersect ENT (XENT) Misses Q2 EPS by 2c
Tweet Send to a Friend
Intersect ENT (NASDAQ: XENT) reported Q2 EPS of ($0.36), $0.02 worse than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
